Physiologic action of glucagon on liver glucose metabolism

Glucagon is a primary regulator of hepatic glucose production (HGP) in vivo during fasting, exercise and hypoglycaemia. Glucagon also plays a role in limiting hepatic glucose uptake and producing the hyperglycaemic phenotype associated with insulin deficiency and insulin resistance. In response to a physiological rise in glucagon, HGP is rapidly stimulated. This increase in HGP is entirely attributable to an enhancement of glycogenolysis, with little to no acute effect on gluconeogenesis. This dramatic rise in glycogenolysis in response to hyperglucagonemia wanes with time. A component of this waning effect is known to be independent of hyperglycemia, though the molecular basis for this tachyphylaxis is not fully understood. In the overnight fasted state, the presence of basal glucagon secretion is essential in countering the suppressive effects of basal insulin, resulting in the maintenance of appropriate levels of glycogenolysis, fasting HGP and blood glucose. The enhancement of glycogenolysis in response to elevated glucagon is critical in the life‐preserving counterregulatory response to hypoglycaemia, as well as a key factor in providing adequate circulating glucose for working muscle during exercise. Finally, glucagon has a key role in promoting the catabolic consequences associated with states of deficient insulin action, which supports the therapeutic potential in developing glucagon receptor antagonists or inhibitors of glucagon secretion.

[1]  D. Edgerton,et al.  Glucagon as a Critical Factor in the Pathology of Diabetes , 2011, Diabetes.

[2]  P. Roach,et al.  Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs. , 2010, The Journal of clinical investigation.

[3]  P. Cryer,et al.  Insulin Reciprocally Regulates Glucagon Secretion in Humans , 2010, Diabetes.

[4]  D. Wasserman,et al.  Hepatic energy state is regulated by glucagon receptor signaling in mice. , 2009, The Journal of clinical investigation.

[5]  O. McGuinness,et al.  Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability. , 2009, American journal of physiology. Endocrinology and metabolism.

[6]  O. McGuinness,et al.  Glucagon chronically impairs hepatic and muscle glucose disposal. , 2007, American journal of physiology. Endocrinology and metabolism.

[7]  O. McGuinness Defective glucose homeostasis during infection. , 2005, Annual review of nutrition.

[8]  O. McGuinness,et al.  Time course of the hepatic adaptation to TPN: interaction with glycogen depletion. , 2005, American journal of physiology. Endocrinology and metabolism.

[9]  S. Kimball,et al.  Glucagon Represses Signaling through the Mammalian Target of Rapamycin in Rat Liver by Activating AMP-activated Protein Kinase* , 2004, Journal of Biological Chemistry.

[10]  O. McGuinness,et al.  Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin. , 2004, American journal of physiology. Endocrinology and metabolism.

[11]  A. Cherrington,et al.  Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog , 1987, Diabetologia.

[12]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[13]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[14]  A. Cherrington,et al.  α- and β-Cell Responses to Small Changes in Plasma Glucose in the Conscious Dog , 2001 .

[15]  A. Cherrington,et al.  Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog. , 2001, Diabetes.

[16]  R. Rizza,et al.  Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. , 2000, The Journal of clinical endocrinology and metabolism.

[17]  A. Cherrington,et al.  Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. , 1999, Diabetes.

[18]  O. McGuinness,et al.  Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection. , 1998, American journal of physiology. Endocrinology and metabolism.

[19]  A. Cherrington,et al.  Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery. , 1997, The American journal of physiology.

[20]  E. Donahue,et al.  Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. , 1997, The Journal of clinical investigation.

[21]  R. Burcelin,et al.  Cloning and sequence analysis of the murine glucagon receptor-encoding gene. , 1995, Gene.

[22]  O. McGuinness,et al.  Effect of acute glucagon removal on metabolic response to infection in conscious dog. , 1995, The American journal of physiology.

[23]  A. Cherrington,et al.  Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs. , 1991, The American journal of physiology.

[24]  M. Diamond,et al.  Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. , 1991, Metabolism: clinical and experimental.

[25]  A. Cherrington,et al.  Effects of insulin on glucagon-stimulated glucose production in the conscious dog. , 1990, Metabolism: clinical and experimental.

[26]  D. Wasserman,et al.  Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. , 1989, The American journal of physiology.

[27]  A. Cherrington,et al.  Role of Brain in Counterregulation of Insulin-Induced Hypoglycemia in Dogs , 1989, Diabetes.

[28]  A. Cherrington,et al.  Role of Gluconeogenesis in Sustaining Glucose Production During Hypoglycemia Caused by Continuous Insulin Infusion in Conscious Dogs , 1988, Diabetes.

[29]  P. Cryer,et al.  Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. , 1985, The New England journal of medicine.

[30]  G. Shulman,et al.  Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. , 1980, Metabolism: clinical and experimental.

[31]  G. Shulman,et al.  Importance of hypoglycemia-induced glucose production during isolated glucagon deficiency. , 1979, The American journal of physiology.

[32]  A. Cherrington,et al.  Effect of glucagon on glucose production during insulin deficiency in the dog. , 1978, The Journal of clinical investigation.

[33]  A. Cherrington,et al.  The Roles of Insulin and Glucagon in the Regulation of Gluconeogenesis in the Postabsorptive Dog , 1977, Diabetes.

[34]  A. Cherrington,et al.  Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. , 1977, The Journal of clinical investigation.

[35]  Jennings,et al.  The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. , 1976, The Journal of clinical investigation.

[36]  J. Gerich,et al.  Characterization of the glucagon response to hypoglycemia in man. , 1974, The Journal of clinical endocrinology and metabolism.

[37]  A. Neely,et al.  Proteolysis in homogenates of perfused rat liver: responses to insulin, glucagon and amino acids. , 1973, Biochemical and biophysical research communications.

[38]  W. A. Müller,et al.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. , 1970, The New England journal of medicine.